Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
In contrast, Eli Lilly (NYSE: LLY) and Hims & Hers Health (NYSE: HIMS) both jumped on today's news. They rose 2.7% and 7%, ...
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Novo Nordisk NVO has outperformed the market over the past 5 years by 3.16% on an annualized basis producing an average ...
Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%
NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.
Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Fierce Biotech5d
'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up
Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has ...
1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street
Viking Therapeutics seems to be doubling down on its hopes of making waves in the weight management market as a stand-alone ...
Novo Nordisk A/S (NVO) Dropped as Trial Results Fell Short of Expectations
Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor ...